Search Results

Atonarp, a leader advancing clinical diagnostics, life science research, semiconductor and industrial process control through digital molecular profiling, announces that James Rothman, Ph.D., has agreed to serve on its board as an independent director.

Atonarp announced today the establishment of its first strategic Advisory Council, consisting of nine distinguished science and technology industry leaders.

Michael Marks, Founding Partner for WRVI Capital, Joins the Atonarp Board and Former Berkeley Lights CFO Shaun Holt Joins as Atonarp’s Chief Operating Officer

Atonarp, a hi-tech molecular diagnostics company, announced that it has raised $33 million in an oversubscribed Series C funding round.

The AMS solution was developed in collaboration between IMA Life, Atonarp and a major pharma company with purpose-built quantitative instrumentation for the application of freeze-drying and aseptic processing.

HepQuant, LLC, a leader transforming the management of liver diseases, announces key additions to its executive leadership team.

Alveo Technologies, Inc. announced the appointment of three life sciences industry leaders to its senior executive team to advance the development of its novel molecular sensing and diagnostics technology and lead the company through strategic growth and commercialization of its rapid, multiplexed molecular diagnostic platform, be.well™.